Jump to content

Joseph Zohar: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
No edit summary
No edit summary
Tags: Reverted possible BLP issue or vandalism possible unreferenced addition to BLP references removed
Line 5: Line 5:
| workplaces = [[Sheba Medical Center]], [[Tel Aviv University]]
| workplaces = [[Sheba Medical Center]], [[Tel Aviv University]]
| education = [[Tel Aviv University]] Sackler School of Medicine, [[Psychiatry]] at [[University of Washington]] ([[Seattle]]) and Jerusalem Mental Health Center
| education = [[Tel Aviv University]] Sackler School of Medicine, [[Psychiatry]] at [[University of Washington]] ([[Seattle]]) and Jerusalem Mental Health Center
| known_for = [[Anxiety disorders]], [[depression (mood)|depression]]
| known_for = [[Post traumatic stress disorder]], [[Obsessive compulsive disorder]], [[Anxiety disorders]], [[depression (mood)|depression]]
| awards = Fogarty International Research Fellowship Award, ECNP Neuropsychopharmacology Award, A. E. Bennet Award for Clinical Research
| awards = Fogarty International Research Fellowship Award, ECNP Neuropsychopharmacology Award, A. E. Bennet Award for Clinical Research, Neuroscience Award for Clinical Research, Lifetime Achievement Award by WPA, Award for Clinicians-Researchers Collaboration Study in Psychiatry, ECNP Honorary Member Award, Aristotle Gold Medal Award}}
}}


'''Joseph Zohar''' ({{lang-he|יוסף זוהר}}; born 18 April 1948) is the director of Psychiatry and the Anxiety and Obsessive Compulsive Clinic at the [[Sheba Medical Center]] in [[Tel HaShomer]] and professor of [[psychiatry]] at [[Tel Aviv University]], [[Israel]]. He is the founder of the World Council on Anxiety as well as the Israeli Consortium on PTSD. He currently leads the chief installation of the [[Israeli Defense Force]] for the treatment of PTSD. He is a member of the executive committee of the [[European College of Neuropsychopharmacology]], of which he is a former president, and chairman of the Expert Platform on Mental Health.
'''Joseph Zohar''' ({{lang-he|יוסף זוהר}}; born 18 April 1948) the Director of the National Post-Trauma Center, Research Foundation by the [[Sheba Medical Center]] in [[Tel HaShomer]] and an emeritus professor of [[psychiatry]] at the Faculty of Medicine, at [[Tel Aviv University]], [[Israel]] at Tel Aviv University.


Prof. Zohar is the current President of the International College of Neuropsychopharmacology (CINP). Past-President of the [[European College of Neuropsychopharmacology]] (ECNP). He is also the founder of the Israeli Consortium on PTSD, the founder of the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS), and a board member of the International Master in Affective Neuroscience.
⚫
==Career==


Prof. Zohar has pioneered and is currently the Chair of an international collaboration (a joint venture of ECNP, ACNP, CINP, AsCNP, and IUPAR) on developing new nomenclature for CNS drugs; NbN - Neuroscience-based Nomenclature. He is also the chair of the Expert Platform on Mental Health focusing on Depression.
===Research focus/interests===

Dr. Zohar heads the Anxiety Clinic at [[Sheba Medical Center]], which specializes in [[anxiety disorder]]s such as [[obsessive-compulsive disorder]], [[post-traumatic stress disorder]], and [[Social anxiety disorder|social phobias]]. In addition to a focus on new treatments, the clinic is interested in the brain function imaging of patients with these [[anxiety disorder]]s.<ref>{{cite web |url= http://eng.sheba.co.il/484/ |title= Sheba Academic Medical Center Hospital: Psychiatric Clinics |author=<!--Staff writer(s); no by-line.--> |website= eng.sheba.co.il/ |access-date= 28 September 2015 }}</ref>
Prof. Zohar was an advisor to DSM – IV and 5 in OCD and co-chair of the Workgroup preparing the research agenda on OCD for DSM-5.

⚫
==Career==


===Notable contributions to research===
===Notable contributions to research===
Zohar is an expert on [[post-traumatic stress disorder]] and has uncovered the potential of secondary prevention in PTSD. His work explores the promising effects of [[hydrocortisone]] treatment when administered after the traumatic event in preventing the development of PTSD.<ref>{{cite journal |title= New insights into secondary prevention in post-traumatic stress disorder |last1= Zohar |first1= Joseph |last2= Juven-Wetzler|first2= Alzbeta |last3= Sonnino|first3= Rachel |last4= Cwikel-Hamzany |first4= Shlomit |last5= Balaban |first5= Evgenya |last6= Cohen |first6= Hagit |date= September 2013 |journal= Dialogues Clin Neurosci |pmc=3182005 |pmid=22033784 |volume=13 |issue= 3 |pages=301–9|doi= 10.31887/DCNS.2011.13.2/jzohar }}</ref>
Prof. Zohar is an expert on [[post-traumatic stress disorder]] and has uncovered the potential of secondary prevention in PTSD. His work explores the promising effects of [[hydrocortisone]] treatment when administered after the traumatic event in preventing the development of PTSD.<ref>{{cite journal |title= New insights into secondary prevention in post-traumatic stress disorder |last1= Zohar |first1= Joseph |last2= Juven-Wetzler|first2= Alzbeta |last3= Sonnino|first3= Rachel |last4= Cwikel-Hamzany |first4= Shlomit |last5= Balaban |first5= Evgenya |last6= Cohen |first6= Hagit |date= September 2013 |journal= Dialogues Clin Neurosci |pmc=3182005 |pmid=22033784 |volume=13 |issue= 3 |pages=301–9|doi= 10.31887/DCNS.2011.13.2/jzohar }}</ref>


===Past appointments===
===Past appointments===
After graduating with his M.D. from Tel Aviv University Sackler School of Medicine, Zohar went on to train in [[psychiatry]] at the [[University of Washington]], [[Seattle]], and at the Jerusalem Mental Health Center in [[Israel]]. While there, Zohar directed the Resistant Depression Unit.
After graduating with his M.D. from Tel Aviv University Sackler School of Medicine, Prof. Zohar went on to train in [[psychiatry]] at the [[University of Washington]], [[Seattle]], and at the Jerusalem Mental Health Center in [[Israel]]. While there, Zohar directed the Resistant Depression Unit.


In 1984, Zohar joined the lab of Dr. Dennis Murphy, at the [[National Institute of Mental Health]] in [[Bethesda, Maryland]]. He was the acting Director of their Obsessive-Compulsive Clinic.<ref name="X">{{cite web |url= https://www.ecnp.eu/~/media/Files/ecnp/communication/webcasts/CV%20Joseph%20Zohar.pdf |title= Joseph Zohar |author=<!--Staff writer(s); no by-line.--> |website= www.ecnp.eu |access-date= 28 September 2015}}</ref>
In 1984, Prof. Zohar joined the lab of Dr. Dennis Murphy, at the [[National Institute of Mental Health]] in [[Bethesda, Maryland]]. He was the acting Director of their Obsessive-Compulsive Clinic.<ref name="X">{{cite web |url= https://www.ecnp.eu/~/media/Files/ecnp/communication/webcasts/CV%20Joseph%20Zohar.pdf |title= Joseph Zohar |author=<!--Staff writer(s); no by-line.--> |website= www.ecnp.eu |access-date= 28 September 2015}}</ref>


⚫
Prof. Zohar was formerly the chairman of the panel for obsessive-compulsive disorders of the American Psychiatric Association Task Force on Treatments of Psychiatric Disorders (1986). In 1992, he established the World Council on Anxiety, known then as the International Council on Anxiety and OCD, and served as its chairman.
⚫
===Awards===
Dr. Zohar has received numerous awards, including the Fogarty International Research Fellowship Award (1984), the A. E. Bennet Award for Clinical Research (1986), the [[European College of Neuropsychopharmacology | European College of Neuropsychopharmacology Award for Clinical Research]] (1998), the World Federation of Societies of Biological Psychiatry Award for Excellence in Education (2001), and he is the co-winner of the A.E. Bennett Award for 2002 for a study on an animal model of PTSD.<ref name="X"/>


⚫
Since 1995 Prof. Zohar has been a member of the executive committee of the [[European College of Neuropsychopharmacology|ECNP]] and chairman of the Israel Society for Biological Psychiatry. In 1996 he was nominated as a member of the WHO Expert Advisory Panel on Neuroscience. In 1997 he was elected to the executive committee of the World Federation of Societies of Biological Psychiatry. He is also chairman of the Brussels-based depression and mental health think-tank, the Expert Platform on Mental Health.
===Positions of trust and research assessments===

⚫
Zohar was formerly the chairman of the panel for obsessive-compulsive disorders of the American Psychiatric Association Task Force on Treatments of Psychiatric Disorders (1986). In 1992, he established the World Council on Anxiety, known then as the International Council on Anxiety and OCD, and served as its chairman. He is the chair of the Anxiety and Obsessive Compulsive Disorders section of the [[World Psychiatric Association]] (WPA).<ref>{{cite web |url= http://www.wpanet.org/uploads/Sections/Anxiety_and_OCD/members-list.pdf
Between 1998-2009, Prof. Zohar was the Associate Secretary-Treasurer & Chairman of the Educational Committee of the World Federation of Biological Psychiatry. In 1999, he was the chair of the Anxiety and Obsessive Compulsive Disorders section of the [[World Psychiatric Association]] (WPA).<ref>{{cite web |url= http://www.wpanet.org/uploads/Sections/Anxiety_and_OCD/members-list.pdf
|title= Anxiety & Obsessive Compulsive Disorders |author=<!--Staff writer(s); no by-line.--> |website= www.wpanet.org |access-date= 28 September 2015}}</ref>
|title= Anxiety & Obsessive Compulsive Disorders |author=<!--Staff writer(s); no by-line.--> |website= www.wpanet.org |access-date= 28 September 2015}}</ref>


In 1999, Prof. Zohar founded and chaired the Israeli consortium on PTSD. In 2003 he was the co-chairman of the committee of DSM/ICD for the preparation of DSM 5 on Obsessive Compulsive Behaviors Spectrum.
⚫
Since 1995 Zohar has been a member of the executive committee of the [[European College of Neuropsychopharmacology|ECNP]] and chairman of the Israel Society for Biological Psychiatry. In 1996 he was nominated as a member of the WHO Expert Advisory Panel on Neuroscience. In 1997 he was elected to the executive committee of the World Federation of Societies of Biological Psychiatry. He is also chairman of the Brussels-based depression and mental health think-tank, the Expert Platform on Mental Health.
Between the years 2004-2013, Zohar served as the vice president, president-elect, and president of [[European College of Neuropsychopharmacology|ECNP]]. Additionally, he founded and chaired the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) between 2004-2012.


Furthermore, Professor Zohar is serving as a special advisor to the Ministry of Defense of Israel concerning PTSD.<ref name="X"/> Since 2021 he has served as a member of the Israeli National Council for Post Trauma and Chaired the “Golden Hours” Committee.
⚫
Joseph Zohar is on the editorial board of the World Journal of Biological Psychiatry,<ref>{{cite web |url= http://www.tandfonline.com/action/journalInformation?show=editorialBoard&journalCode=iwbp20 |title= The World Journal of Biological Psychiatry Editorial Board |author=<!--Staff writer(s); no by-line.--> |website= www.tandfonline.com |access-date= 28 September 2015}}</ref> the CNS Spectrum<ref>{{cite web |url= http://journals.cambridge.org/action/displayMoreInfo?jid=CNS&type=eb&sessionId=0A9A8C2C630965DB3DA1FF0BA7B6D9A4.journals |title= CNS Spectrums – Journal Editorial Board |author=<!--Staff writer(s); no by-line.--> |website= journals.cambridge.org |access-date= 28 September 2015}}</ref>

Today, Professor Zohar is the current President of the International College of Neuropsychopharmacology (CINP) and has served as a vice president and as president-elect of CINP since 2018.
⚫
Professor Zohar is on the editorial board of the World Journal of Biological Psychiatry,<ref>{{cite web |url= http://www.tandfonline.com/action/journalInformation?show=editorialBoard&journalCode=iwbp20 |title= The World Journal of Biological Psychiatry Editorial Board |author=<!--Staff writer(s); no by-line.--> |website= www.tandfonline.com |access-date= 28 September 2015}}</ref> the CNS Spectrum<ref>{{cite web |url= http://journals.cambridge.org/action/displayMoreInfo?jid=CNS&type=eb&sessionId=0A9A8C2C630965DB3DA1FF0BA7B6D9A4.journals |title= CNS Spectrums – Journal Editorial Board |author=<!--Staff writer(s); no by-line.--> |website= journals.cambridge.org |access-date= 28 September 2015}}</ref>
and several other journals.
and several other journals.


⚫
===Awards===
He founded the Israeli consortium on PTSD, is currently the commander of the chief installation of the [[Israeli Defense Force]] for treating PTSD, and he is serving as a special advisor to the Ministry of Defense in relation to PTSD.<ref name="X"/>
Professor Zohar had been honored with several awards, including the Fogarty International Research Fellowship Award (1984), the A.E. Bennet Award for Clinical Research (1986 and 2002), ECNP Neuroscience Award for Clinical Research (1998), and the WFSBP Award for Excellence in Education (2001), the Life Achievement Award by the Israeli Psychiatric Association (2018), Award for Clinicians-Researchers Collaboration Study in Psychiatry, by The Israel Society for Biological Psychiatry and The National Institute of Psychobiology in Israel (2019), and Mentor Award by Israel Society of Biological Psychiatry (2021), ECNP Honorary Member Award (2023), and Aristotle Gold Medal Award (2024).<ref name="X"/>

===Grants===
Professor Zohar has received funding (RO1) from the National Institute of Mental Health (NIMH) to explore secondary prevention of PTSD (2012), and from NATO (2018) to develop a guideline on the treatment in the ‘Golden Hours’ after a terror attack. He is also the Co-Chair of the EU COST grant on Problematic Use of Internet PUI (2017), and the USA Department of Defense (DoD) Grant (in collaboration with Mount Sinai Hospital, NY) on Hydrocortisone, ‘Golden Hours’ and secondary prevention of PTSD (2019), and the EU Grant on Horizon Europe Framework Program (HORIZON) for Boosting Societal Adaptation and Mental Health in Rapidly Digitalizing, Post Pandemic Europe (Bootstrap), (2022). He also received funding from NATO (2018) for Digital Tools for Prevention, Mitigation, and Treatment of Traumatic Stress Responses in Terror and War (2023).


==Publications==
==Publications==
He is the author of more than 400 scientific papers and has edited 18 books focusing on refractory depression, obsessive-compulsive disorder, and [[Posttraumatic stress disorder|PTSD]].<ref name="X"/><ref>{{cite web |url= https://www.researchgate.net/profile/Joseph_Zohar |title= Joseph Zohar |author=<!--Staff writer(s); no by-line.--> |website= www.researchgate.net |access-date= 28 September 2015}}</ref>
Professor Zohar is the author of more than 450 scientific papers and has edited 20 books focusing on resistant depression, obsessive-compulsive disorder, [[Posttraumatic stress disorder|PTSD]] and Neuroscience-based Nomenclature (NbN) .<ref name="X"/><ref>{{cite web |url= https://www.researchgate.net/profile/Joseph_Zohar |title= Joseph Zohar |author=<!--Staff writer(s); no by-line.--> |website= www.researchgate.net |access-date= 28 September 2015}}</ref>



==References==
==References==

Revision as of 14:30, 16 January 2024

Joseph Zohar
יוסף זוהר
Born (1948-04-18) 18 April 1948 (age 76)
EducationTel Aviv University Sackler School of Medicine, Psychiatry at University of Washington (Seattle) and Jerusalem Mental Health Center
Known forPost traumatic stress disorder, Obsessive compulsive disorder, Anxiety disorders, depression
AwardsFogarty International Research Fellowship Award, ECNP Neuropsychopharmacology Award, A. E. Bennet Award for Clinical Research, Neuroscience Award for Clinical Research, Lifetime Achievement Award by WPA, Award for Clinicians-Researchers Collaboration Study in Psychiatry, ECNP Honorary Member Award, Aristotle Gold Medal Award
Scientific career
FieldsPsychiatry
InstitutionsSheba Medical Center, Tel Aviv University

Joseph Zohar (Template:Lang-he; born 18 April 1948) the Director of the National Post-Trauma Center, Research Foundation by the Sheba Medical Center in Tel HaShomer and an emeritus professor of psychiatry at the Faculty of Medicine, at Tel Aviv University, Israel at Tel Aviv University.

Prof. Zohar is the current President of the International College of Neuropsychopharmacology (CINP). Past-President of the European College of Neuropsychopharmacology (ECNP). He is also the founder of the Israeli Consortium on PTSD, the founder of the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS), and a board member of the International Master in Affective Neuroscience.

Prof. Zohar has pioneered and is currently the Chair of an international collaboration (a joint venture of ECNP, ACNP, CINP, AsCNP, and IUPAR) on developing new nomenclature for CNS drugs; NbN - Neuroscience-based Nomenclature. He is also the chair of the Expert Platform on Mental Health focusing on Depression.

Prof. Zohar was an advisor to DSM – IV and 5 in OCD and co-chair of the Workgroup preparing the research agenda on OCD for DSM-5.

Career

Notable contributions to research

Prof. Zohar is an expert on post-traumatic stress disorder and has uncovered the potential of secondary prevention in PTSD. His work explores the promising effects of hydrocortisone treatment when administered after the traumatic event in preventing the development of PTSD.[1]

Past appointments

After graduating with his M.D. from Tel Aviv University Sackler School of Medicine, Prof. Zohar went on to train in psychiatry at the University of Washington, Seattle, and at the Jerusalem Mental Health Center in Israel. While there, Zohar directed the Resistant Depression Unit.

In 1984, Prof. Zohar joined the lab of Dr. Dennis Murphy, at the National Institute of Mental Health in Bethesda, Maryland. He was the acting Director of their Obsessive-Compulsive Clinic.[2]

Prof. Zohar was formerly the chairman of the panel for obsessive-compulsive disorders of the American Psychiatric Association Task Force on Treatments of Psychiatric Disorders (1986). In 1992, he established the World Council on Anxiety, known then as the International Council on Anxiety and OCD, and served as its chairman.

Since 1995 Prof. Zohar has been a member of the executive committee of the ECNP and chairman of the Israel Society for Biological Psychiatry. In 1996 he was nominated as a member of the WHO Expert Advisory Panel on Neuroscience. In 1997 he was elected to the executive committee of the World Federation of Societies of Biological Psychiatry. He is also chairman of the Brussels-based depression and mental health think-tank, the Expert Platform on Mental Health.

Between 1998-2009, Prof. Zohar was the Associate Secretary-Treasurer & Chairman of the Educational Committee of the World Federation of Biological Psychiatry. In 1999, he was the chair of the Anxiety and Obsessive Compulsive Disorders section of the World Psychiatric Association (WPA).[3]

In 1999, Prof. Zohar founded and chaired the Israeli consortium on PTSD. In 2003 he was the co-chairman of the committee of DSM/ICD for the preparation of DSM 5 on Obsessive Compulsive Behaviors Spectrum. Between the years 2004-2013, Zohar served as the vice president, president-elect, and president of ECNP. Additionally, he founded and chaired the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) between 2004-2012.

Furthermore, Professor Zohar is serving as a special advisor to the Ministry of Defense of Israel concerning PTSD.[2] Since 2021 he has served as a member of the Israeli National Council for Post Trauma and Chaired the “Golden Hours” Committee.

Today, Professor Zohar is the current President of the International College of Neuropsychopharmacology (CINP) and has served as a vice president and as president-elect of CINP since 2018.

Professor Zohar is on the editorial board of the World Journal of Biological Psychiatry,[4] the CNS Spectrum[5] and several other journals.

Awards

Professor Zohar had been honored with several awards, including the Fogarty International Research Fellowship Award (1984), the A.E. Bennet Award for Clinical Research (1986 and 2002), ECNP Neuroscience Award for Clinical Research (1998), and the WFSBP Award for Excellence in Education (2001), the Life Achievement Award by the Israeli Psychiatric Association (2018), Award for Clinicians-Researchers Collaboration Study in Psychiatry, by The Israel Society for Biological Psychiatry and The National Institute of Psychobiology in Israel (2019), and Mentor Award by Israel Society of Biological Psychiatry (2021), ECNP Honorary Member Award (2023), and Aristotle Gold Medal Award (2024).[2]

Grants

Professor Zohar has received funding (RO1) from the National Institute of Mental Health (NIMH) to explore secondary prevention of PTSD (2012), and from NATO (2018) to develop a guideline on the treatment in the ‘Golden Hours’ after a terror attack. He is also the Co-Chair of the EU COST grant on Problematic Use of Internet PUI (2017), and the USA Department of Defense (DoD) Grant (in collaboration with Mount Sinai Hospital, NY) on Hydrocortisone, ‘Golden Hours’ and secondary prevention of PTSD (2019), and the EU Grant on Horizon Europe Framework Program (HORIZON) for Boosting Societal Adaptation and Mental Health in Rapidly Digitalizing, Post Pandemic Europe (Bootstrap), (2022). He also received funding from NATO (2018) for Digital Tools for Prevention, Mitigation, and Treatment of Traumatic Stress Responses in Terror and War (2023).

Publications

Professor Zohar is the author of more than 450 scientific papers and has edited 20 books focusing on resistant depression, obsessive-compulsive disorder, PTSD and Neuroscience-based Nomenclature (NbN) .[2][6]


References

  1. ^ Zohar, Joseph; Juven-Wetzler, Alzbeta; Sonnino, Rachel; Cwikel-Hamzany, Shlomit; Balaban, Evgenya; Cohen, Hagit (September 2013). "New insights into secondary prevention in post-traumatic stress disorder". Dialogues Clin Neurosci. 13 (3): 301–9. doi:10.31887/DCNS.2011.13.2/jzohar. PMC 3182005. PMID 22033784.
  2. ^ a b c d "Joseph Zohar" (PDF). www.ecnp.eu. Retrieved 28 September 2015.
  3. ^ "Anxiety & Obsessive Compulsive Disorders" (PDF). www.wpanet.org. Retrieved 28 September 2015.
  4. ^ "The World Journal of Biological Psychiatry Editorial Board". www.tandfonline.com. Retrieved 28 September 2015.
  5. ^ "CNS Spectrums – Journal Editorial Board". journals.cambridge.org. Retrieved 28 September 2015.
  6. ^ "Joseph Zohar". www.researchgate.net. Retrieved 28 September 2015.
Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Joseph_Zohar&oldid=1196137632"